申请人:MERCK & CO INC
公开号:WO2010014453A1
公开(公告)日:2010-02-04
The instant invention provides for compounds that inhibit the four known mammalian JAK kinases (JAK1, JAK2, JAK3 and TYK2). The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting the activity of JAK1, JAK2, JAK3 and TYK2 by administering the compound to a patient in need of treatment for myeloproliferative disorders or cancer.
这项即时发明提供了抑制四种已知哺乳动物JAK激酶(JAK1、JAK2、JAK3和TYK2)的化合物。该发明还提供了包含这种抑制性化合物的组合物以及通过向需要治疗骨髓增生性疾病或癌症的患者施用该化合物来抑制JAK1、JAK2、JAK3和TYK2活性的方法。